GLP-1 prescriptions rose 24% from 2018 to 2025 as surgery fell. Tulane's Dr. Shauna Levy says Louisiana insurers cover surgery more often than the drugs.
Recap by typeshit. Full story at WWBT.
A Facebook post says US researchers found pancreatic cells producing GLP-1 on their own. It frames this as a possible built-in appetite and sugar control system, without naming the study.
Researchers are studying whether GLP-1 drugs, which act on mood, appetite and reward pathways, could help with depression, addiction and binge eating.
A retrospective cohort checks whether retinal disease started or worsened more in established users than in people never on either drug, plus a regional NAION review.
24:34
An animated explainer walking through what semaglutide does in the body, from appetite signals in the brain to digestion and blood sugar control.
A JAMA Network Surgery study found GLP-1 prescriptions up 24% since 2018. A Tulane surgeon says in Louisiana, surgery is more often covered than the drugs.
STAT
STAT, citing the AP, notes the peptides involved aren't FDA approved as safe or effective and most of their data comes from animal studies.
Loading…